Cabaletta Bio

Quarterly Financials

Values in thousands 2025-06-30 2025-03-31 2024-12-31 2024-09-30
Revenue
$0
$0
$1,638
$0
Gross Profit
-468
-485
819
-424
EBITDA
-44,089
-37,136
-23,292
-32,622
EBIT
-44,557
-37,621
-23,760
-33,046
Net Income
-45,128
-35,943
-32,586
-30,629
Net Change In Cash
0
0
1,638
0
Free Cash Flow
-30,587
-31,587
-23,498
-20,576
Cash
145,612
131,830
163,962
170,608
Basic Shares
61,876
49,471
50,198
49,471

Annual Financials

Values in thousands 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Revenue
$0
$0
$0
$0
Gross Profit
-4,813
-1,426
-3,684
-733
EBITDA
-125,141
-73,234
-52,961
-45,580
EBIT
-116,612
-74,660
-54,139
-46,313
Net Income
-115,864
-67,675
-51,811
-45,532
Net Change In Cash
0
0
0
0
Cost of Revenue
-40,615
Free Cash Flow
-90,433
-54,236
-48,833
-35,275
Cash
163,962
193,238
81,607
122,222
Basic Shares
49,471
40,946
29,343
25,737

Earnings Calls

Quarter EPS
2025-09-30
$0
2025-06-30
-$0.73
2025-03-31
-$0.65
2024-12-31
-$0.65